Radical prostatectomy as treatment for prostate-specific antigen-detected stage T1c prostate cancer


The use of serum prostate-specific antigen (PSA) measurement as a method for early detection of prostate cancer has increased the detection of clinically and pathologically localized prostate cancer. Clinical stage T1c was introduced to describe cancers discovered on prostate biopsy as a result of an abnormal serum PSA level without a palpable prostatic… (More)
DOI: 10.1007/BF01300186


7 Figures and Tables